Original Research

Cost-Effectiveness and Budget Impact Analyses of Tisagenlecleucel in Pediatric and Young Adult Patients with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia from the Singapore Healthcare System Perspective

Wang XJ, Wang YH, Ong MJC, Gkitzia C, Soh SY, Hwang WYK

ClinicoEconomics and Outcomes Research 2022, 14:333-355

Published Date: 3 May 2022